California California Franchise Tax Board [Member] Percentage held by non-affiliates Sale of Stock Available for Sale, Percentage Sale of Stock Available for Sale, Percentage Options, Vested and expected to vest, Weighted Average Remaining Contractual Term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Statistical Measurement [Domain] Statistical Measurement [Domain] Gross Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Cover [Abstract] Cover [Abstract] BOLSTER trial Bolster Trial [Member] Bolster Trial Warrants Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] Net increase (decrease) in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Warrants, Vested and expected to vest (in shares) shares, vested and expected to vest shares, vested and expected to vest Schedule of Future Minimum Lease Payments Under Lease Agreements Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Income Tax Authority [Domain] Income Tax Jurisdiction [Domain] Trading Symbol Trading Symbol Ownership percentage Equity Method Investment, Ownership Percentage All Trading Arrangements All Trading Arrangements [Member] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Non-NEOs Non-NEOs [Member] Vesting term Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Tax credit carryforward Tax Credit Carryforward, Amount Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Pay vs Performance Disclosure [Line Items] Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Share based compensation expense Share Based Compensation Expense, General And Administrative Expense Share Based Compensation Expense, General And Administrative Expense Accounts receivable Increase (Decrease) in Accounts Receivable Long-lived Assets Property, Plant and Equipment, Impairment [Policy Text Block] Loss Per Share Earnings Per Share, Policy [Policy Text Block] Description of Business Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Fair Value Measurements Fair Value Disclosures [Text Block] Proceeds from exercise of options Proceeds from Stock Options Exercised Option to terminate Research Collaboration and License Agreement, Option to Terminate Research Collaboration and License Agreement, Option to Terminate Available for sale securities - net unrealized loss OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Award Timing Disclosures [Line Items] Investment, Name [Domain] Investment, Name [Domain] Other Performance Measure, Amount Other Performance Measure, Amount Research Tax Credit Carryforward Research Tax Credit Carryforward [Member] Schedule of Restricted Stock Units Activity Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Warrants, Vested, Weighted Average Exercise Price (in dollars per share) Weighted Average Exercise Price, Warrants Exercisable Weighted Average Exercise Price, Warrants Exercisable Operating Leases Lessee, Operating Leases [Text Block] Common stock outstanding (in shares) Common stock, beginning balance (in shares) Common stock, ending balance (in shares) Common Stock, Shares, Outstanding Less than one year Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Remainder of Fiscal Year Sale of marketable securities Proceeds from Sale and Maturity of Marketable Securities Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Segment Information Segment Reporting, Policy [Policy Text Block] Research and Development Costs Research, Development, and Computer Software, Policy [Policy Text Block] Other assets Other Assets, Noncurrent Entity Tax Identification Number Entity Tax Identification Number Leases [Abstract] Leases [Abstract] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Money market funds Money Market Funds [Member] Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Treasury Stock Treasury Stock, Common [Member] Sublicensing fee Collaborative Arrangement, Rights and Obligations, Sublicensing Fees Collaborative Arrangement, Rights and Obligations, Sublicensing Fees Shares canceled (in shares) Investment Owned, Canceled, Shares Investment Owned, Canceled, Shares Statement, Equity Components [Axis] Equity Components [Axis] Award Timing Method Award Timing Method [Text Block] SAFE, discount rate SAFE, Discount Rate SAFE, Discount Rate Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Options, Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Estimated Fair Value Total Debt Securities, Available-for-Sale Accounts Receivable Accounts Receivable [Policy Text Block] Warrants, Weighted Average Exercise Price, Vested or expected to vest in the future (in dollars per share) Weighted Average Exercise Price, Warrants Vested And Expected To Vest Weighted Average Exercise Price, Warrants Vested And Expected To Vest Measurement Frequency [Axis] Measurement Frequency [Axis] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Insider Trading Policies and Procedures [Line Items] Municipal debt securities US States and Political Subdivisions Debt Securities [Member] Use of Estimates Use of Estimates, Policy [Policy Text Block] Annual license maintenance fee Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee Adjustment to Compensation, Amount Adjustment to Compensation Amount Options, Outstanding, Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Compensation Amount Outstanding Recovery Compensation Amount Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Entity Small Business Entity Small Business Accrued Liabilities Accounts Payable and Accrued Liabilities Disclosure [Text Block] Company Selected Measure Amount Company Selected Measure Amount Tabular List, Table Tabular List [Table Text Block] Level 3 Fair Value, Inputs, Level 3 [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-Sale [Line Items] Accrued liabilities Total Accrued Liabilities, Current Antidilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Cash, cash equivalents and marketable securities Cash and Cash Equivalents And Marketable Securities Cash and Cash Equivalents And Marketable Securities Kuva Kuva [Member] Kuva Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Other Research And Development, Other [Member] Research And Development, Other Amortization/accretion on marketable securities Accretion (Amortization) of Discounts and Premiums, Investments Unrecognized compensation cost Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Consolidation Items [Axis] Consolidation Items [Axis] Accounts receivable, allowance for credit loss Accounts Receivable, Allowance for Credit Loss Tax withholding payments on net share settlement equity awards Payment, Tax Withholding, Share-Based Payment Arrangement Other comprehensive gain (loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] Treasury stock (in shares) Treasury Stock, Common, Shares Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Product and Service [Domain] Product and Service [Domain] Stock options Share-Based Payment Arrangement, Option [Member] Schedule of Available-for-sale Securities [Table] Debt Securities, Available-for-Sale [Table] Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Depreciation Depreciation Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] License License [Member] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Comprehensive loss attributable to Lisata Therapeutics, Inc. common stockholders Comprehensive Income (Loss), Net of Tax, Attributable to Parent Technology Transfer Agreement [Abstract] Technology Transfer Agreement Warrants Warrants Warrant [Member] Security Exchange Name Security Exchange Name Potential milestone payments Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Per Product Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Per Product Schedule of Investments Classified by Contractual Maturity Date Investments Classified by Contractual Maturity Date [Table Text Block] Award Type [Axis] Award Type [Axis] Corporate debt securities Corporate Debt Securities [Member] Income Tax Holiday [Table] Income Tax, Holiday [Table] Options, Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Warrants, Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Property and equipment, net Property and equipment, net Property, Plant and Equipment, Net Total liabilities Liabilities Non-controlling interests Equity, Attributable to Noncontrolling Interest Common stock, par value (in usd per share) Common Stock, Par or Stated Value Per Share Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Foreign Currency Remeasurement Foreign Currency Transactions and Translations Policy [Policy Text Block] Expiration Date Trading Arrangement Expiration Date Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Restricted Stock Units Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward] Investment owned (in shares) Investment Owned, Balance, Shares Shares held by third party (in shares) Shares Held by Third Party Shares Held by Third Party Operating lease liabilities — current Accrued liabilities Operating Lease, Liability, Current Total Shareholder Return Amount Total Shareholder Return Amount Common stock, shares issued (in shares) Common Stock, Shares, Issued Income tax incentive receivable Income Tax Incentive Receivable Income Tax Incentive Receivable Schedule of Restricted Stock Activity Nonvested Restricted Stock Shares Activity [Table Text Block] Entity [Domain] Entity [Domain] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Computer equipment Computer equipment Computer Equipment [Member] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Property and equipment, gross Property, Plant and Equipment, Gross ASCEND trial Ascend Trial [Member] Ascend Trial Proceeds from option exercises (in shares) Options, Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Accounts receivable Accounts Receivable, after Allowance for Credit Loss Warrants, Granted (in shares) Warrants Granted Warrants Granted Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Research and development Research and Development Expense [Member] Stock Options, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Unrealized loss on marketable securities OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax Diluted shares (in shares) Weighted Average Number of Shares Outstanding, Diluted Warrants Outstanding, Beginning of Period (in dollars per share) Warrants Outstanding, End of Period (in dollars per share) Weighted Average Exercise Price, Warrants Outstanding Weighted Average Exercise Price, Warrants Outstanding MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Expected amortization, remainder of fiscal year Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Less than one year Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Remainder of Fiscal Year Total Lisata Therapeutics, Inc. stockholders' equity Equity, Attributable to Parent Operating Lease Liabilities: Operating Lease, Liability [Abstract] License Agreements Research Collaboration and License Agreement Collaborative Arrangement Disclosure [Text Block] Litigation Case [Axis] Litigation Case [Axis] Property and Equipment Property, Plant and Equipment Disclosure [Text Block] Investment income, net Investment Income, Net General and administrative Selling, General and Administrative Expense Recurring Fair Value, Recurring [Member] Investments in and Advances to Affiliates [Line Items] Investments in and Advances to Affiliates [Line Items] Sale of Stock, Name of Transaction [Domain] Sale of Stock [Domain] Right-of-Use Assets: Operating Lease, Right-Of-Use Asset [Abstract] Operating Lease, Right-Of-Use Asset Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Document Fiscal Period Focus Document Fiscal Period Focus All Executive Categories All Executive Categories [Member] Expected amortization, year two Finite-Lived Intangible Asset, Expected Amortization, Year Two Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Options, Outstanding, Weighted Average Remaining Contractual Term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term ASSETS Assets [Abstract] Warrants, Vested and expected to vest, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Term, Warrants Vested and Expect to Vest Weighted Average Remaining Contractual Term, Warrants Vested and Expect to Vest Total other comprehensive gain (loss) Other Comprehensive Income (Loss), Net of Tax Document Type Document Type Clinical department Clinical Department [Member] Clinical Department Value of shares issued Stock Issued During Period, Value, Restricted Stock Award, Gross Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Number of shares issued (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Gross Software Computer Software, Intangible Asset [Member] Purchase of marketable securities Payments to Acquire Marketable Securities Exclusive License and Collaboration Agreement Exclusive License and Collaboration Agreement [Member] Exclusive License and Collaboration Agreement Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Cost Debt Securities, Available-for-Sale, Amortized Cost Total Lisata Therapeutics, Inc. Stockholders' Equity Parent [Member] Operating loss carryforwards, post acquisition Operating Loss Carryforwards, Post Acquisition Operating Loss Carryforwards, Post Acquisition Maximum Maximum [Member] Amortization of intangible assets Amortization of Intangible Assets Debt Securities, Available-for-sale [Abstract] Debt Securities, Available-for-Sale [Abstract] Contract with customer, liability Contract with Customer, Liability Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Furniture and fixtures Furniture and Fixtures [Member] Acquired license - intangible, net Finite-Lived Intangible Assets, Net Antidilutive Securities [Axis] Antidilutive Securities [Axis] Accounts payable Accounts Payable, Current Accounting Policies [Abstract] Accounting Policies [Abstract] Liabilities Liabilities [Abstract] Warrants Outstanding, Aggregate Intrinsic Value Aggregate Intrinsic Value, Warrants Outstanding Aggregate Intrinsic Value, Warrants Outstanding Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Leasehold improvements Leasehold Improvements [Member] Options, Expired (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Schedule of Fair Value of Share-based Compensation Awards Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Current Fiscal Year End Date Current Fiscal Year End Date Less: Amounts representing interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Statistical Measurement [Axis] Statistical Measurement [Axis] PEO Name PEO Name Collaborative Arrangement, Transaction with Party to Collaborative Arrangement Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Net loss before benefit from income taxes and noncontrolling interests Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Award Type [Domain] Award Type [Domain] Name Outstanding Recovery, Individual Name Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Share-based compensation (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] ATM Agreement At The Market Offering Agreement [Member] At The Market Offering Agreement Non-PEO NEO Non-PEO NEO [Member] Intangible asset, useful life Finite-Lived Intangible Asset, Useful Life Marketable securities - available-for-sale Investments, Fair Value Disclosure Additional Paid-in Capital Additional Paid-in Capital [Member] Award Timing Predetermined Award Timing Predetermined [Flag] Warrants, Vested, Weighted Average Remaining Contractual Term weighted Average Remaining Contractual Term, Warrants Vested weighted Average Remaining Contractual Term, Warrants Vested Class of Stock [Line Items] Class of Stock [Line Items] Investment, Name [Axis] Investment, Name [Axis] Warrants, Outstanding, Beginning of Period (in shares) Warrants, Outstanding, End of Period (in shares) Common Stock Warrants, Shares Common Stock Warrants, Shares Other Other General and Administrative Expense Lisata Therapeutics, Inc. common stockholders - diluted (in usd per share) Earnings Per Share, Diluted Counterparty Name [Domain] Counterparty Name [Domain] Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Name Measure Name State State and Local Jurisdiction [Member] Entity Interactive Data Current Entity Interactive Data Current Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Litigation settlement, first milestone payment Litigation Settlement, Milestone Payment Litigation Settlement, Milestone Payment Total Cash, Cash Equivalents, and Short-Term Investments Intangible Assets Intangible Assets, Finite-Lived, Policy [Policy Text Block] Number of operating segments Number of Operating Segments Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued NOL annual limitation Net Carryforward Operating Loss Carryforward Annual Limitation Net Carryforward Operating Loss Carryforward Annual Limitation Warrants, Vested, Aggregate Intrinsic Value Aggregate Intrinsic Value, Warrants Vested Aggregate Intrinsic Value, Warrants Vested Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Treasury bills US Treasury Bill Securities [Member] Net loss Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Basic and diluted loss per share EPS [Abstract] EPS Benefit from income taxes Income Tax Expense (Benefit) Other income (expense): Nonoperating Income (Expense) [Abstract] Segment Reporting, Reconciling Item, Corporate Nonsegment Segment Reporting, Reconciling Item, Corporate Nonsegment [Member] Warrants, Weighted Average Contractual Term and Intrinsic Value Warrants Other Disclosures [Abstract] Warrants Other Disclosures Expected weighted-average period in years of compensation cost to be recognized Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Revenue excluding taxes Revenue from Contract with Customer, Excluding Assessed Tax Investment in Impilo Therapeutics Payments to Acquire Intangible Assets Total other income Nonoperating Income (Expense) Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] New York New York State Division of Taxation and Finance [Member] Cash equivalents Cash Equivalents, at Carrying Value Stock Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest [Abstract] Effective income tax rate reconciliation Effective Income Tax Rate Reconciliation, Percent Net cash provided by investing activities Net Cash Provided by (Used in) Investing Activities Operating loss Operating Income (Loss) Income Tax Authority [Axis] Income Tax Jurisdiction [Axis] Research and development Research and Development Expense (Excluding Acquired in Process Cost) Total liabilities, non-controlling interests and stockholders' equity Liabilities and Equity Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] All Adjustments to Compensation All Adjustments to Compensation [Member] Salaries, employee benefits and related taxes Employee-related Liabilities, Current Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Marketable Securities Marketable Securities, Policy [Policy Text Block] Prepaid and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Additional paid-in capital Additional Paid in Capital Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Tax Credit Carryforward [Axis] Tax Credit Carryforward [Axis] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Legal Entity [Axis] Legal Entity [Axis] Technology Transfer Agreement Technology Transfer Agreement [Text Block] Technology Transfer Agreement Cash and marketable securities Cash, Cash Equivalents, and Marketable Securities Cash, Cash Equivalents, and Marketable Securities Underlying Security Market Price Change Underlying Security Market Price Change, Percent Tax Credit Carryforward, Name [Domain] Tax Credit Carryforward, Name [Domain] Individual: Individual [Axis] Common stock, value, outstanding Common Stock, Value, Outstanding Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Options, Forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Finance Finance, General And Administrative Expense Finance, General And Administrative Expense Product and Service [Axis] Product and Service [Axis] Entity Address, State or Province Entity Address, State or Province Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Statement [Line Items] Statement [Line Items] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Litigation settlement, future milestone payments Litigation Settlement, Future Milestone Payments, Percent Litigation Settlement, Future Milestone Payments, Percent Operating Expenses: Operating Expenses [Abstract] Schedule of Property, Plant and Equipment Property, Plant and Equipment [Table Text Block] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Financial Instruments [Domain] Financial Instruments [Domain] Shares issued under license agreement (in shares) Shares Issued Under License Agreement Shares Issued Under License Agreement Sale of stock available for sale Sale of Stock Available for Sale Sale of Stock Available for Sale Beginning balance (in dollars per share) Ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value LIABILITIES, NON-CONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY Liabilities and Equity [Abstract] Investor relations/public relations/communications Communications and Information Technology Minimum Minimum [Member] Restatement Determination Date Restatement Determination Date Options, Vested and expected to vest (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Royalty Royalty [Member] Adoption Date Trading Arrangement Adoption Date Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Annual license maintenance fee, year seven Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee Starting at Year Seven Collaborative Arrangement, Rights and Obligations, Annual License Maintenance Fee Starting at Year Seven Schedule of Available-for-sale Securities Reconciliation Schedule of Available-for-Sale Securities Reconciliation [Table Text Block] SAFE, valuation cap SAFE, Valuation Cap SAFE, Valuation Cap Loss on sale of NOL Loss On Sale of NOL Loss On Sale of NOL Proceeds from sale of NOLs, gross Proceeds From Sale Of Net Operating Losses, NJEDA Program, Gross Proceeds From Sale Of Net Operating Losses, NJEDA Program, Gross Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Options, Outstanding. Beginning of Period (in dollars per share) Options, Outstanding, End of Period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Right-of-use assets Operating Lease, Right-of-Use Asset Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Options, Outstanding, Beginning of Period (in shares) Options, Outstanding, End of Period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Segments [Axis] Segments [Axis] Warrants, Exercised (in dollars per share) Weighted Average Exercise Price, Warrants Exercised Weighted Average Exercise Price, Warrants Exercised Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Schedule of Total Compensation Cost Related to Nonvested Awards Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block] Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Exercise Price Award Exercise Price Income (Loss) Per Share Earnings Per Share [Text Block] Arrangement Duration Trading Arrangement Duration Net operating loss carryforwards Operating Loss Carryforwards Proceeds from option exercises Stock Issued During Period, Value, Stock Options Exercised Research tax credit rate Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent Warrants, Expired (in shares) Warrants Expired Warrants Expired Stockholders' Equity Equity, Attributable to Parent [Abstract] Weighted average estimated fair value (in dollars per share) Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Warrants, Exercised (in shares) Warrants Exercised Warrants Exercised Federal Domestic Tax Jurisdiction [Member] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Segment [Domain] Segments [Domain] Chemistry, manufacturing and controls Chemistry Manufacturing And Controls [Member] Chemistry Manufacturing And Controls Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Impilo Impilo [Member] Impilo All Individuals All Individuals [Member] PEO PEO [Member] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Name Trading Arrangement, Individual Name Other expense, net Other income, net Other Nonoperating Income (Expense) Royalties, net of sales Collaborative Arrangement, Rights and Obligations, Royalties Net of Sales Collaborative Arrangement, Rights and Obligations, Royalties Net of Sales Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Warrants, Vested (in shares) Warrants, Vested Warrants, Vested Gross Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Loss from equity method investment Equity method investment expense Income (Loss) from Equity Method Investments Treasury stock, at cost; 738 shares at March 31, 2025 and December 31, 2024 Treasury Stock, Common, Value Options, Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Lingmed Limited Lingmed Limited [Member] Lingmed Limited Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Options, Vested, Weighted Average Remaining Contractual Term Options, Vested, Weighted Average Remaining Contractual Term Options, Vested, Weighted Average Remaining Contractual Term Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Greater than one year Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Available-for-Sale-Securities Cash, Cash Equivalents, and Marketable Securities [Text Block] Local Phone Number Local Phone Number Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Total operating expenses Operating Expenses Stock Options, Weighted Average Contractual Term and Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Other assets Increase (Decrease) in Other Operating Assets Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Litigation settlement, payment term Litigation Settlement, Payment Term Litigation Settlement, Payment Term PEO Total Compensation Amount PEO Total Compensation Amount Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Income Statement Location [Axis] Statement of Income Location, Balance [Axis] Options, Vested and expected to vest (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Contingencies Commitments and Contingencies Disclosure [Text Block] Common Stock Common Stock [Member] Measure: Measure [Axis] Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Net proceeds from issuances of common stock (in shares) Stock issued (in shares) Stock Issued During Period, Shares, New Issues Revenue, Major Customer [Line Items] Revenue, Major Customer [Line Items] CEND CEND [Member] CEND Options, Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures Entity Emerging Growth Company Entity Emerging Growth Company Right-of-use assets, balance sheet line item Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Segment Reporting [Abstract] Segment Reporting [Abstract] Entity Central Index Key Entity Central Index Key Reportable Segment Reportable Segment [Member] Reportable Segment General and administrative General and Administrative Expense [Member] Accrued Liabilities [Abstract] Accrued Liabilities [Abstract] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Warrants, Expired (in dollars per share) Weighted Average Exercise Price, Warrants Expired Weighted Average Exercise Price, Warrants Expired Stockholders' Equity Equity [Text Block] Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Equity Component [Domain] Equity Component [Domain] Financial Instrument [Axis] Financial Instrument [Axis] Segment Information Segment Reporting Disclosure [Text Block] Warrants, Vested and expected to vest, Aggregate Intrinsic Value Aggregate Intrinsic Value, Warrants Vested And Expected To Vest Aggregate Intrinsic Value, Warrants Vested And Expected To Vest Warrants, Forfeited (in shares) Warrants Canceled Warrants Canceled Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Percentage of sublicensing revenues Revenue, Performance Obligation, Percentage of Sublicensing Revenues Revenue, Performance Obligation, Percentage of Sublicensing Revenues Share-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Restricted Stock Restricted Stock [Member] Entity Shell Company Entity Shell Company Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Percentage of net sale Revenue, Performance Obligation, Percentage of Net Sale Revenue, Performance Obligation, Percentage of Net Sale Title Trading Arrangement, Individual Title Statement [Table] Statement [Table] Counterparty Name [Axis] Counterparty Name [Axis] Measurement Frequency [Domain] Measurement Frequency [Domain] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Unrecognized tax benefits Unrecognized Tax Benefits Consolidation Items [Domain] Consolidation Items [Domain] City Area Code City Area Code Agency bonds Bonds [Member] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Level 1 Fair Value, Inputs, Level 1 [Member] Cumulative translation adjustment arising during the period Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Total current assets Assets, Current Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Variable consideration amounts, milestones Revenue, Remaining Performance Obligation, Variable Consideration Amount Revenue, Remaining Performance Obligation, Variable Consideration Amount Marketable securities Marketable securities Marketable Securities Fair value market of tax NOLs Fair Value Market of Tax NOLs Fair Value Market of Tax NOLs Weighted average estimated fair value of shares granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted Average Grant-Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Income Taxes Income Tax Disclosure [Text Block] Earnings Per Share [Abstract] Earnings Per Share [Abstract] Aggregate offering amount authorized per agreement Sale Of Stock, Aggregate Offering Amount Authorized Per Agreement Sale Of Stock, Aggregate Offering Amount Authorized Per Agreement Equity [Abstract] Equity [Abstract] Less - net income (loss) attributable to noncontrolling interests Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest Estimated Fair Value Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract] Accumulated deficit Retained Earnings (Accumulated Deficit) In-process Research and Development Expense In Process Research and Development, Policy [Policy Text Block] Accounts payable, accrued liabilities and other liabilities Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities General and administrative General and Administrative Expense Litigation settlement, amount awarded to other party Litigation Settlement, Amount Awarded to Other Party Outstanding stock threshold Outstanding Stock Threshold Outstanding Stock Threshold Net operating loss carryforwards, prior to write down Operating Loss Carryforwards, Before Write Down Operating Loss Carryforwards, Before Write Down Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Equity Awards Adjustments Equity Awards Adjustments [Member] Weighted average discount rate for operating leases (percent) Operating Lease, Weighted Average Discount Rate, Percent Total Operating Lease Liabilities Present value of lease liabilities Operating Lease, Liability Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Underlying Securities Award Underlying Securities Amount Warrants, Weighted Average Exercise Price Warrants Weighted Average Exercise Price [Roll Forward] Warrants Weighted Average Exercise Price [Roll Forward] Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] Amendment Flag Amendment Flag Entity Registrant Name Entity Registrant Name Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Fair Value as of Grant Date Award Grant Date Fair Value Options, Vested and expected to vest, Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Level 2 Fair Value, Inputs, Level 2 [Member] Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy and NAV [Domain] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Business development Business Development Net proceeds from issuances of common stock Stock Issued During Period, Value, New Issues Milestones, Royalties Collaborative Arrangement, Accounting Policy [Policy Text Block] Accounting & tax consulting liabilities Accrued Grant Funding Accrued Grant Funding Entity Address, Postal Zip Code Entity Address, Postal Zip Code Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Schedule Share-based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Principles of Consolidation Consolidation, Policy [Policy Text Block] Restatement Determination Date: Restatement Determination Date [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Title of 12(b) Security Title of 12(b) Security Common stock, $0.001 par value, authorized 500,000,000 shares; issued 8,620,900 and 8,409,582 shares at March 31, 2025 and December 31, 2024, respectively; and outstanding, 8,620,162 and 8,408,844 shares at March 31, 2025 and December 31, 2024, respectively Common Stock, Value, Issued Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Income Tax Authority, Name [Domain] Income Tax Authority, Name [Domain] Greater than one year Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Schedule of Investments [Table] Schedule of Investments [Table] Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Warrants, Forfeited (in dollars per share) Weighted Average Exercise Price, Warrants Canceled Weighted Average Exercise Price, Warrants Canceled Options, Vested, Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Warrants, Granted (in dollars per share) Weighted Average Exercise Price, Warrants Granted Weighted Average Exercise Price, Warrants Granted Sanford Burnham Prebys Sanford Burnham Prebys [Member] Sanford Burnham Prebys Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Warrants, Outstanding, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Term Warrant Outstanding Weighted Average Remaining Contractual Term Warrant Outstanding Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Operating lease liabilities, current, balance sheet line item Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Useful life Property, Plant and Equipment, Useful Life Stock Options, Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Clinical and R&D related liabilities Clinical and R&D Related Liabilities Clinical and R&D Related Liabilities Lisata Therapeutics, Inc. common stockholders- basic (in usd per share) Earnings Per Share, Basic Net proceeds from issuance of common stock Proceeds from Issuance of Common Stock Income Tax Holiday [Line Items] Income Tax Holiday [Line Items] Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Schedule of Stock by Class [Table] Stock, Class of Stock [Table] Total current liabilities Liabilities, Current Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Weighted average common shares outstanding Weighted Average Number of Shares Outstanding, Diluted [Abstract] Total assets Assets Concentration of Risks Concentration Risk, Credit Risk, Policy [Policy Text Block] Expected amortization, year one Finite-Lived Intangible Asset, Expected Amortization, Year One Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Schedule of Assets Measured at Fair Value on Recurring Basis Fair Value, Assets Measured on Recurring Basis [Table Text Block] Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment Share-based compensation Issuance of Stock and Warrants for Services or Claims Other long-term liabilities Other Liabilities, Noncurrent Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Commitments and Contingencies (Note 14) Commitments and Contingencies Share-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Termination Date Trading Arrangement Termination Date Legal Legal, General And Administrative Expense Legal, General And Administrative Expense Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Share-Based Compensation Share-Based Payment Arrangement [Text Block] Entity Address, City or Town Entity Address, City or Town Leases Lessee, Leases [Policy Text Block] Schedule of Stock Option and Warrants Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Total share-based compensation expense Share-Based Payment Arrangement, Expense Revenue from collaborative arrangement Revenue from contract Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer Net loss attributable to Lisata Therapeutics, Inc. common stockholders Net Income (Loss) Attributable to Parent Net Income (Loss) Attributable to Parent Trading Arrangement: Trading Arrangement [Axis] Options, Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Loss Contingencies [Table] Loss Contingencies [Table] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Foreign Tax Authority Foreign Tax Jurisdiction [Member] Entity File Number Entity File Number Operating Leases Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Proceeds from sale of NOLs Proceeds From Sale of NOLS Proceeds From Sale of NOLS Australia Research and Development Tax Incentive Research and Development Tax Incentive [Text Block] Research and Development Tax Incentive Document Fiscal Year Focus Document Fiscal Year Focus Non- Controlling Interest in Subsidiary Noncontrolling Interest [Member] Income Statement [Abstract] Income Statement [Abstract] Entity Address, Address Line One Entity Address, Address Line One Effect of exchange rate changes on cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Other Other Accrued Liabilities, Current Assets, fair value disclosure Assets, Fair Value Disclosure Name Forgone Recovery, Individual Name 2025 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Weighted average remaining lease term for operating leases (in years) Operating Lease, Weighted Average Remaining Lease Term Document Period End Date Document Period End Date Sale of Stock [Axis] Sale of Stock [Axis] Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Total lease payments Lessee, Operating Lease, Liability, to be Paid Beginning balance (in shares) Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Options, Expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Insider Trading Arrangements [Line Items] New Jersey New Jersey Division of Taxation [Member] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract] Schedule of Marketable Securities Marketable Securities [Table Text Block] Adjustment to Compensation: Adjustment to Compensation [Axis] Prepaid and other current assets Prepaid Expense and Other Assets, Current Document Transition Report Document Transition Report Schedule of Revenue by Major Customers, by Reporting Segments [Table] Schedule of Revenue by Major Customers, by Reporting Segments [Table] Document Quarterly Report Document Quarterly Report Payments to acquire Impilo SAFE Payments to Acquire Other Investments Litigation Case [Domain] Litigation Case [Domain] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Current Reporting Status Entity Current Reporting Status Accumulated Deficit Retained Earnings [Member] Qilu Qilu [Member] Qilu Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Income Tax Authority, Name [Axis] Income Tax Authority, Name [Axis] Basic shares (in shares) Weighted Average Number of Shares Outstanding, Basic Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Schedule of Operating Lease Liabilities and Right-of-Use Assets on Balance Sheet Lessee, Operating Lease, Balance Sheet Presentation [Table Text Block] Lessee, Operating Lease, Balance Sheet Presentation [Table Text Block] Total equity Beginning balance Ending balance Equity, Including Portion Attributable to Noncontrolling Interest Restricted stock units Restricted Stock Units (RSUs) [Member] Treasury Stock Stockholders' Equity, Policy [Policy Text Block] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Executive Category: Executive Category [Axis] Name Awards Close in Time to MNPI Disclosures, Individual Name Options, Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Entity Filer Category Entity Filer Category Total fair value of shares vested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Operating loss carryforwards subject to expiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration Total share-based compensation expense Statement of Income Location, Balance [Domain] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Company Selected Measure Name Company Selected Measure Name